QVF testifies at the FDA - November 5, 2015
About this video:
The Quinolone Vigilance Foundation testified at the FDA on November 5, 2015, where the FDA advisory panel heard testimony about the risks/benefits of fluoroquinolone antibiotics for routine infections such as sinus infections, UTIs, and bronchitis. The panel heard us and voted that the risks outweigh the benefits. The panel is advising the FDA to restrict the use of fluoroquinolones to life threatening infections.